Health Catalyst NASDAQ: HCAT stockholders approved three of four proposals presented at the company's 2026 annual meeting, including the election of two directors, ratification of the company's auditor and an advisory vote on executive compensation. A proposal to phase out the company's classified board structure did not receive the required level of support.
Health Catalyst, Inc. (HCAT) Q1 2026 Earnings Call Transcript
Health Catalyst NASDAQ: HCAT reported first-quarter 2026 results that topped its own expectations, while management outlined a broad restructuring plan aimed at simplifying the company's operating model, reducing costs and shifting the business further toward technology-led growth.
| Health Care Providers & Services Industry | Healthcare Sector | Benjamin Albert CEO | XFRA Exchange | 42225T107 CUSIP |
| US Country | 1,200 Employees | - Last Dividend | - Last Split | 25 Jul 2019 IPO Date |
Health Catalyst, Inc. specializes in providing advanced data and analytics technology along with services for healthcare organizations across the United States. The company operates through its two primary segments: Technology and Professional Services. With its roots going back to 2008, and originally known as HQC Holdings, Inc., the entity rebranded itself to Health Catalyst, Inc. in March 2017. Headquartered in South Jordan, Utah, Health Catalyst stands as a pivotal player in transforming healthcare data into actionable insights, optimizing client operations, and enhancing patient care.
Health Catalyst’s offerings can be categorized into several key areas, detailed as follows: